BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Business

  Politically Connected Patrick Soon-Shiong Questioned Over Genetic Tests

  Patrick Soon-Shiong touted sales of his closely scrutinized test without revealing the purchaser was on his payroll.

  November 6, 2017

   · 

  1 min read
• Business

  Guangzhou Pharma May Form China Generics JV With Teva Pharma

  November 6, 2017

   · 

  1 min read
• 

  Policy

  TherapeuticsMD Soars on Plans to Resubmit TX-004HR NDA Without New Pre-Approval Study

  Shares of TherapeuticsMD have shot up more than 51 percent in morning trading after the FDA reversed course on its rejection of that company’s vaginal pain medication.

  November 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Former ArthroCare CEO Draws 20 Year Prison Sentence

  Baker and ex-ArthroCare CFO Michael Gluk were convicted in June 2014 on charges that they ran a scheme to generate false revenue numbers

  November 6, 2017

   · 

  1 min read
• 

  BioMidwest

  This is the Average Interview Process Time for a Biopharma Job

  How long does it take to go from application to job offer at a typical life sciences company?

  November 6, 2017

   · 

  6 min read

   · 

  Mark Terry
• Business

  Enesi Pharma Appoints New International Scientific Advisory Board

  The SAB includes experts in vaccines and preventative health from leading academic/ research and international health organisations in the US and Europe.

  November 6, 2017

   · 

  3 min read
• 

  Business

  The Battle Between Two $1B+ Biotech Unicorns

  Two of the top companies in the field are German-based CureVac and U.S.-based Moderna Therapeutics.

  November 6, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  FDA

  FDA Approves Genentech’s Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease

  People diagnosed with the rare blood disorder known as Erdheim-Chester disease have a new treatment option.

  November 6, 2017

   · 

  2 min read

   · 

  Alex Keown
• Drug Development

  Debiopharm International SA Announces Dosing of First Patient in a Combination Trial of Debio 1143 and Avelumab in Patients with Solid Tumors Including NSCLC

  The trial is being conducted under a clinical collaboration agreement announced last year between Debiopharm International SA and the Merck-Pfizer Alliance.

  November 6, 2017

   · 

  5 min read
• Drug Development

  AVEO Oncology and EUSA Pharma Announce Promising Phase I Results From the Phase I/II TiNivo Study of Tivozanib and Nivolumab in Renal Cell Carcinoma

  No grade 4 adverse events were reported.

  November 6, 2017

   · 

  8 min read